Navigation Links
Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
Date:8/19/2007

WESTMINSTER, Colo., Aug. 15 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced the initiation of patient enrollment in a Phase 1, open-label, multi-center study of the Company's novel antifolate PDX (pralatrexate) with vitamin B12 and folic acid supplementation in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL).

"Based on our experience with PDX in patients with peripheral T-cell lymphoma, we're excited to initiate this study in patients with cutaneous T- cell lymphoma and view this effort as a natural progression of our PDX development program in hematologic malignancies," said Pablo J. Cagnoni, M.D., Chief Medical Officer of Allos. "Therapies currently used to treat cutaneous T-cell lymphoma fail to produce durable remissions in the majority of patients with advanced disease."

In this study, patients with either relapsed or refractory cutaneous T- cell lymphoma will receive PDX as part of a weekly schedule for two or three weeks followed by one week of rest. Patients will receive starting doses of PDX at 30 mg/m2, with dose reduction in subsequent cohorts based on toxicity. Up to 56 evaluable patients will be enrolled in the study with the objective of determining the optimal dose and safety profile of PDX in this population. A total of 20 of these patients will be enrolled at what is determined to be the optimal dose and schedule. Steven Horwitz, M.D., Assistant Attending Physician, Lymphoma Service, Memorial Sloan-Kettering Cancer Center, will serve as the study chair.

"Given the evidence of activity observed to date with PDX in patients with aggressive T-cell lymphomas, coupled with the common cell lineage between PTCL and CTCL, there is a str
'/>"/>

SOURCE Allos Therapeutics, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
2. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
6. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
11. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... /PRNewswire-iReach/ -- SAM Medical Products Implements Voluntary Recall ... Junctional Tourniquet.  Photo - ... announced today that it has begun notifying customers ... issue with a clip used to secure the ... the SAM Junctional Tourniquet (SJT).  The company discovered ...
(Date:8/29/2014)... , Aug. 29, 2014  A Boston Scientific ... study on stent removability and preliminary long term ... published in the August issue of the peer-reviewed ... 1 is being conducted in 11 countries ... covered self-expanding metal stents (FCSEMS) after extended indwell ...
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... 1 October is American Pharmacists Month and ... provide outstanding care to their patients every day ... specialty pharmacies across the country. (Logo: ... Pharmacists Month is a time to recognize the ...
... national initiative, the Pediatric Trials Network (PTN), was created ... the National Institutes of Health (NIH).  The PTN will ... Shriver National Institute of Child Health and Human ... medical centers, including Children,s Mercy Hospitals and Clinics.   ...
Cached Medicine Technology:CVS Caremark Recognizes Its 26,000 Pharmacists During October's American Pharmacists Month 2New National Program to Study and Establish Pediatric Dosing 2New National Program to Study and Establish Pediatric Dosing 3
(Date:8/30/2014)... Atlanta based automotive group Jim Ellis ... money and awareness for ALS by participating in the ... and even Vice President Jimmy Ellis all participated in ... be viewed on their Youtube page; https://www.youtube.com/watch?v=pxufyxVo9j0 . ... managers and staff also took the opportunity to challenge ...
(Date:8/30/2014)... Fast hosting is a great choice for webmasters ... professional web hosting suppliers and announces that Bluehost, ... suppliers of fastest web hosting in 2014. , ... hosting supplier. Actually, these companies have outperformed their ... customer support. People can get the best web ...
(Date:8/30/2014)... 2014 United Theological Seminary is pleased to ... the Master of Theological Studies (MTS). , ... designed for students who wish to pursue further academic study ... to serve the Church and community. Previously, students needed to ... can attend classes from any location where there is an ...
(Date:8/30/2014)... Daily Gossip reveals in its recently published review that the ... Sarah Summer, who can perfectly understand what suffering from yeast ... actually had to deal with this disorder, too. Her method ... it, in an all-natural holistic cure program. , So, Sarah ... for yeast infection. The author of this program suffered from ...
(Date:8/30/2014)... Hicksville, NY (PRWEB) August 30, 2014 ... Organizations throughout the planet has been one of ... in order to create a positive impact around ... aesthetics and staffed with top trained executives and ... millions of people worldwide. Vital statistics demonstrate ...
Breaking Medicine News(10 mins):Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Natural Cure for Yeast Infection Review Exposes New Natural Treatment 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2
... importance of a gap between bad news and request , , ... to donate -- or not donate -- a dying relative,s ... and when it,s made are key, U.K. researchers have found. ... at the same time that relatives are told their loved ...
... BOSTON, April 22 Wainwright Bank & Trust Company (Nasdaq: ... closed on a complex New Markets Tax Credit financing structure ... providing clinical treatment, job training and job placement for recovering ... New Markets Tax Credit Allocation (as the controlling entity of ...
... N.Y., April 22 Misonix, Inc. (Nasdaq: ... device technology, which in Europe is used for the ... conditions, has entered into a definitive, 5-year distribution agreement ... Under the terms of the agreement, DTL will market ...
... ingredients contained in the anti-oxidant LiverLife has been shown ... in children with Autism Spectrum Disorder.LAGUNA HILLS, Calif., April ... chemical age, accumulating toxins that weaken the immune system. ... significantly lowers the immune response to allergens in ...
... Overcharging Employers and Driving Up Healthcare Costs ... System (WPAHS) yesterday filed a complaint in United ... system, and Highmark, Inc., Pittsburgh,s dominant health insurer, ... protect one another from competition," with the result ...
... The American Society of Hypertension, Inc. ... initiative in hypertension and related cardiovascular disease -- the ... of education of allied health professionals and pharmaceutical sales ... to meet the educational needs of each of the ...
Cached Medicine News:Health News:Timing May Matter in Organ Donation Decisions 2Health News:Wainwright Bank Provides $10 Million in New Markets Tax Credits and $7.4 Million in Financing to Hope House 2Health News:Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria 2Health News:Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria 3Health News:BioRay's LiverLife Reduces Food Allergies in Autistic Children 2Health News:West Penn Allegheny Health System Files Lawsuit Charging UPMC, Highmark with Conspiracy, Antitrust 2Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 2Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 3Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 4
... it comes to medication administration, any error ... make. The solution is the Dynamic Hospital ... bar-coded medication administration system, suitable for hospitals ... used stand-alone, networked, or as a fully-integrated ...
... that support the nursing process. The caregiver ... I&O information at the point of collection ... This design supports compliance with documentation requirements., ... at the nursing station, wCareAssist™ is right ...
... that identifies the patient, tying all critical information to the patient's unique bar-coded identifier for accurate, easy recording ... ... ... ...
The Metrologic MS9520 Voyager is a high performance single line laser bar code scanner with automatic activation and sophisticated data transmission via Metrologic proprietary CodeGate technology....
Medicine Products: